FFA
ABBV icon

Fi3 Financial Advisors’s AbbVie ABBV Stock Holding History

Fi3 Financial Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$642K Buy
7,080
+5,266
+290% +$1.13M 0.15% 78
2026
Q1 		$395K Sell
1,814
-131
-7% -$29.1K 0.11% 100
2025
Q4 		$444K Sell
1,945
-59
-3% -$13.4K 0.14% 86
2025
Q3 		$464K Sell
2,004
-150
-7% -$30.5K 0.16% 62
2025
Q2 		$400K Buy
2,154
+51
+2% +$9.48K 0.14% 68
2025
Q1 		$441K Sell
2,103
-59
-3% -$11.5K 0.18% 52
2024
Q4 		$384K Buy
2,162
+4
+0.2% +$735 0.14% 58
2024
Q3 		$426K Sell
2,158
-614
-22% -$115K 0.17% 47
2024
Q2 		$476K Sell
2,772
-58
-2% -$9.61K 0.21% 38
2024
Q1 		$464K Buy
2,830
+122
+5% +$21K 0.21% 38
2023
Q4 		$420K Sell
2,708
-89
-3% -$13K 0.2% 46
2023
Q3 		$417K Buy
2,797
+282
+11% +$41.4K 0.22% 40
2023
Q2 		$339K Sell
2,515
-338
-12% -$49.6K 0.18% 44
2023
Q1 		$455K Buy
2,853
+149
+6% +$22.8K 0.24% 41
2022
Q4 		$437K Buy
2,704
+617
+30% +$94.6K 0.25% 39
2022
Q3 		$280K Buy
+2,087
New +$299K 0.26% 35

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fi3 Financial Advisors's ABBV Position: Q2 2026 in Review

Fi3 Financial Advisors increased its AbbVie (ABBV) stake by 290% in Q2 2026, buying an estimated $1.13M and bringing the position to 7,080 shares worth $642K. The position accounts for 0.15% of the portfolio, ranked #78.

Fi3 Financial Advisors first reported a position in ABBV in Q3 2022 and has held it in 16 quarters since. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Fi3 Financial Advisors held 7,080 shares of AbbVie worth $642K as of Q2 2026.
  • Fi3 Financial Advisors bought 5,266 AbbVie shares in Q2 2026, an estimated $1.13M.
  • AbbVie made up 0.15% of Fi3 Financial Advisors's portfolio in Q2 2026, its #78 holding.
  • Fi3 Financial Advisors first reported a position in AbbVie in Q3 2022 and has held it in 16 quarters since.
  • 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Fi3 Financial Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.